NEA leads a big syn­di­cate on $100M mega-round for Al­lakos

Five years af­ter get­ting start­ed with a $32 mil­lion Se­ries A, the crew at Al­lakos in San Car­los, CA are get­ting a $100 mil­lion mega-round to put their lead drug to the test.

New En­ter­prise As­so­ciates led the round for the low pro­file biotech with a big syn­di­cate that in­cludes Red­mile Group, Part­ner Fund Man­age­ment, Rock Springs Cap­i­tal, LifeSci Ven­ture Part­ners, Sam­sara Bio­Cap­i­tal, and “a large in­sti­tu­tion­al in­vestor,” as well as ex­ist­ing in­vestors Al­ta Part­ners, River­Vest Ven­ture Part­ners, Roche Ven­ture Fund, and 3X5 Part­ners.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER